id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-309302-n6cd2fc3	Wang, Li	Clinical management of lung cancer patients during the outbreak of COVID-19 epidemic	2020-09-23		.txt	text/plain	5674	318	46	In this review, we focus on the epidemiological characteristics, early diagnosis, patient management and mental health of lung cancer patients during the COVID-19 epidemic. According to China's New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 8), drugs with potential antiviral effects should be used early in the course of the disease, and it is recommended to focus on patients with high risk factors for severe illness patients. However, hydroxychloroquine or combined azithromycin is not recommended for COVID-19 patients base on China's New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 8). In addition, convalescent plasma is suitable for patients with rapid disease progression, severe and critically ill patients base on China's New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 8). According to China's New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 8), Tocilizumab can be tried for patients with extensive lung disease and elevated IL-6 levels in the laboratory.	./cache/cord-309302-n6cd2fc3.txt	./txt/cord-309302-n6cd2fc3.txt